The Editor of Drugs, the definitive journal of drugs and therapeutics, providing independent and crucial information by leading clinicians and researchers.
New Zealand
Joined March 2010
- Tweets943
- Following399
- Followers277
- Likes319
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure - leading article by Professor Yun-Fan Liaw, Liver Research Unit, Chang Gung University College of Medicine, Taiwan just published in @DrugsJournal #HepatitisB link.springer.com/article/10…
Latest issue of @drugsjournal now available online link.springer.com/journal/40… C. difficile infection, refractory #SLE, autoimmune #epilepsy syndromes, intraperitoneal chemotherapy, Nirsevimab (Beyfortus®) in #RSV and Rezvilutamide (艾瑞恩®) in #prostatecancer
In patients with osteoarthritis or back pain, there were no differential risks of incident #Covid_19 diagnosis or COVID-19 hospitalisation for #ibuprofen users compared with other ns-NSAIDs, COX-2i or paracetamol. link.springer.com/article/10…
Congratulations
My first, first author paper is now published in @DrugsJournal🎉This review discusses current GIST TKI treatments and how our understanding of the molecular mechanisms of the GIST subtypes can inform the development of more successful targeted therapies. link.springer.com/article/10…
First original research for the year in @DrugsJournal, "An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers" from Roger Brüggemann and colleagues link.springer.com/article/10…
Just published in the latest issue of @DrugsJournal First Approvals on ozoralizumab (Nanozora®) for rheumatoid arthritis and tremelimumab-actl (IMJUDO®) for a range of malignant tumours link.springer.com/journal/40…
And now in the news medicalxpress.com/news/2022-…
Great review on gabapentinoids (gabapentin or pregabalin) for pain just published in @DrugsJournal with authors suggesting prescribers should be cautious, particularly with using these agents for a prolonged period #pain link.springer.com/article/10…
Great review on gabapentinoids (gabapentin or pregabalin) for pain just published in @DrugsJournal with authors suggesting prescribers should be cautious, particularly with using these agents for a prolonged period #pain link.springer.com/article/10…
This very complete article is available open access @DrugsJournal link.springer.com/article/10…
🔥Brandnew review on new antifungals in clinical trials! @DrugsJournal
Looking forward to see them in clinical use! Sincere thanks @martinhoenigl @CornelyOliver @Amir36520680 @JeffreyJenks5 @jprattes @GRThompsonMD
Fantastic figures from @matteosciart
🔗bit.ly/3DpGTX9
The innovative Silicon Valley-based medical journal, Cureus, is now part of the health division of Springer Nature - helping to solve some challenges of open access publishing. group.springernature.com/gp/…
Just published in the latest issue of @DrugsJournal First Approvals on Darinaparsin (Darvias®) for peripheral T-cell lymphoma; Teclistamab (TECVAYLI®) for multiple myeloma and Valemetostat tosilate (EZHARMIA®) for non-Hodgkin lymphomas link.springer.com/journal/40…
Just published in @DrugsJournal Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors by Editorial Board members Francesco Locatelli and Lucia Del Vecchio and colleagues link.springer.com/article/10…
Adis Insight reports on first approvals just published in @DrugsJournal Lenacapavir (Sunlenca®) for HIV-1 infection and Valoctocogene roxaparvovec (ROCTAVIAN™) for haemophilia link.springer.com/journal/40…
Dene Peters retweeted
International validation of a #MRSA risk assessment tool for skin and soft tissue infections link.springer.com/article/10…
Dene Peters retweeted
Let Springer Nature support you in the fight against #monkeypox. Explore Springer Nature’s curated collection of articles and book chapter. Additionally, don’t miss out to check the trials related to monkeypox: bit.ly/3T3fUbo
Dene Peters retweeted
NEW "Trends in the Use of Sedative-Hypnotics, #OPIOIDS, and Neuromuscular Blockers in Hospitalized Patients During the #COVID19 Pandemic"
👉Rapid changes in the use of these #DRUGS were evident during 2020 in Colombia.
Full-text:
link.springer.com/article/10…
#OpenAccess
Dene Peters retweeted
This #realworld study investigated safety and clinical outcomes of macitentan in a post-marketing study involving Korean patients with pulmonary arterial #hypertension enrolled from 50 medical centers
#OpenAccess
Full-text available here:
link.springer.com/article/10…
Dene Peters retweeted
Please visit our
CLINICAL MYCOLOGY @YouTube Channel
posting videos of some of the latest and 🔥🔥 scientific webinars educational presentations in the field.
Never miss an update by
Subscribing here👇
youtube.com/channel/UCKdGfw7…
Dene Peters retweeted
#IDTwitter
Do you treat patients? please fill out survey by @AnnetteWestgst & @VanceFowler5 on management of S. aureus bacteremia.
It should take < 15 minutes, is IRB approved, voluntary, and anonymous.
Please RT
@ABsteward @IdVilchez @ErinMcCreary
redcap.duke.edu/redcap/surve… – at Raleigh, NC
Dene Peters retweeted
Here's a recently published guide for plain language summaries @Emerald_CG @slowcabbage @PECjournal @PatientJournal researchinvolvement.biomedce…
